- Acoramidis demonstrated a significant reduction in risk of CVM through 42 months post-randomization, with a 44% hazard reduction, setting a new standard for CVM outcomes for patients with ATTR-CM - ...

PALO ALTO, Calif., Aug. 30, 2025 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a new type of biopharmaceutical company focused on genetic diseases, ...

Acoramidis-mediated Improvement in NT-proBNP at Month 30 Compared with Placebo in Patients with ATTR-CM: Results from the ATTRibute-CM StudyPresenter: Nitasha Sarswat, M.D. of UChicago Medicine, ...

PALO ALTO, Calif., Aug. 25, 2025 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a new type of biopharmaceutical company focused on genetic diseases, ...

Attruby is a transthyretin stabilizer indicated for the treatment of the cardiomyopathy of wild-type or variant transthyretin-mediated amyloidosis (ATTR-CM) in adults to reduce cardiovascular death ...

To achieve a similar visual appeal and layout in a desktop GUI, you'd typically rely on: Frames/Layout Managers: To organize elements like the timer, question cards, and options. Labels: For text like ...

First, create a new instance of the Label widget. Second, place the Label on the main window by calling the pack() method. If you don’t call the pack() function, the program still creates the label ...

Hey there! In this tutorial, I’m going to help you understand how Tkinter event binding works. It’s a cool feature in Tkinter that allows you to connect functions to specific events. Basically, when ...

In the phase 3 randomized controlled study ATTRibute-CM (Efficacy and Safety of AG10 in Subjects With Transthyretin Amyloid Cardiomyopathy), acoramidis, a transthyretin stabilizer, demonstrated ...